SALE: For a limited time only we are offering Patent Investor+ for $249/mo. Learn More
Sep 8, 2017
1 min read
Amp Continues to Add ARRY to its Portfolio This Week
Ahead of its presentations at the European Society for Medical Oncology (ESMO) annual meeting this week, Amp added a stake in Array Biopharma (ARRY) to its hypothetical fund earlier in the week, and is increasing that stake today.